| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 05/15/2002 | CN1349508A Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
| 05/15/2002 | CN1349413A Contraceptive compositions containing quinazolinone and benzoxazine derivatives |
| 05/15/2002 | CN1084736C Substituted bheterocyclic carboxamide esters, their prepn. and their use as pharmaceuticals |
| 05/15/2002 | CN1084619C Process for preparing medicine composition |
| 05/14/2002 | US6388094 Method for making intermediates useful in synthesis of retroviral protease inhibitors |
| 05/14/2002 | US6388092 Antitumor agent |
| 05/14/2002 | US6388081 4-substituted-quinoline derivatives and 4-substituted-quinoline combinatorial libraries |
| 05/14/2002 | US6387929 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 05/14/2002 | US6387892 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 05/14/2002 | US6387547 Compound having naphthacene skeleton for use in organic electroluminescence device; produces light emission of satisfactory luminance, especially at long wavelength; improved light emitting performance lasts for long time |
| 05/14/2002 | US6387389 Sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use |
| 05/10/2002 | WO2002036734A2 Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors |
| 05/10/2002 | WO2002036570A1 4-substituted quinolines as antitumor agents |
| 05/10/2002 | WO2002036569A1 N-type calcium channel antagonists for the treatment of pain |
| 05/10/2002 | WO2002036568A1 N-type calcium channel antagonists for the treatment of pain |
| 05/10/2002 | WO2002036567A1 N-type calcium channel antagonists for the treatment of pain |
| 05/10/2002 | WO2002036566A1 Agrochemical composition |
| 05/10/2002 | WO2002036556A2 Acylaminoalkyl-substituted benzenesulfonamide derivatives |
| 05/10/2002 | WO2002036555A1 Sulfamides as gamma-secretase inhibitors |
| 05/10/2002 | WO2002018342A3 Novel autoinducer molecules and uses therefor |
| 05/10/2002 | WO2001023389A3 Certain alkylene diamine-substituted heterocycles |
| 05/10/2002 | CA2425067A1 Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors |
| 05/10/2002 | CA2425023A1 Agrochemical composition |
| 05/09/2002 | US20020055631 N-acylsulfonamide apoptosis promoters |
| 05/09/2002 | US20020055522 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury. |
| 05/09/2002 | US20020055516 Nitrogen-containing heterocyclic compounds and medicaments containing the compounds |
| 05/08/2002 | EP1203767A1 Heterocyclic-substituted alkylamide acat inhibitors |
| 05/08/2002 | EP1203766A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 05/08/2002 | EP1202972A2 Method for preparing quinoline-5,8-diones |
| 05/08/2002 | EP1202971A2 Pharmaceutical compositions comprising 4-quinolones |
| 05/08/2002 | EP1202961A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 05/08/2002 | DE10054481A1 Acylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate Acylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical compositions containing them |
| 05/08/2002 | CN1084330C Cydic amide derivatives |
| 05/08/2002 | CN1084328C Aryloxyane amine compounds, its prepn. and application |
| 05/07/2002 | US6384224 For therapy and prophylaxis of psychotic disorders such as schizophrenia and other central nervous system disease |
| 05/07/2002 | US6384075 Treating diseases in which mast cell dysfunction is involved |
| 05/02/2002 | WO2002034760A2 Compounds and methods |
| 05/02/2002 | WO2002034745A1 Chemokine receptor binding heterocyclic compounds |
| 05/02/2002 | WO2002034712A1 Process for preparing substituted aromatic compounds and intermediates therefor |
| 05/02/2002 | WO2002034048A1 Agrochemical compositions with quinoline safeners |
| 05/02/2002 | WO2001090074A3 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 05/02/2002 | WO2001081298A3 Cyclic carboxylic acids as integrin antagonists |
| 05/02/2002 | WO2001052829A3 Statin-type bone growth stimulators |
| 05/02/2002 | US20020052512 Diaminopropionic acid derivatives |
| 05/02/2002 | US20020052509 Calcilytic compounds and method of use |
| 05/02/2002 | US20020052399 In particular as inhibitors of HIV protease. |
| 05/02/2002 | US20020052391 Tetrahydroquinoline derivatives as glycine antagonists |
| 05/02/2002 | US20020052379 Highly homogeneous form; stable pharmaceutical dosage forms, including an aqueous suspension |
| 05/02/2002 | US20020052378 Novel compounds and compositions as protease inhibitors |
| 05/02/2002 | US20020052356 Quinoline and quinazoline derivatives; prophylaxis or treatment of arthritis, cardiovascular diseases, diabetes, renal failure and particularly eating disorders and obesity. |
| 05/02/2002 | EP1201648A1 Carbamate derivatives and agricultural/horticultural bactericides |
| 05/02/2002 | EP1200408A2 Bonding agent |
| 05/02/2002 | EP1200396A1 Naphthylsulfonic acids and related compounds as glucose uptake agonists |
| 05/02/2002 | EP1200395A1 Urea derivatives as inhibitors of ccr-3 receptor |
| 05/02/2002 | EP0615448B1 Sex steroid activity inhibitors |
| 05/02/2002 | CA2422870A1 Agrochemical compositions with quinoline safeners |
| 05/02/2002 | CA2421796A1 Chemokine receptor binding heterocyclic compounds |
| 04/30/2002 | US6380384 Anxiolytic agents |
| 04/30/2002 | US6380258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 04/30/2002 | US6380188 For inhibiting human immunodeficiency virus protease |
| 04/30/2002 | CA2131761C Crystals of pyridonecarboxylic acid derivative |
| 04/25/2002 | WO2002032874A2 Substituted heterocyclic compounds for treating multidrug resistance |
| 04/25/2002 | WO2002032872A1 Nitrogenous aromatic ring compounds |
| 04/25/2002 | WO2002032871A2 Compounds and methods for treating multidrug resistance |
| 04/25/2002 | WO2002032869A2 Substituted heterocyclic compounds for treating multidrug resistance |
| 04/25/2002 | WO2002032868A2 2-substituted heterocyclic compounds and their use in treating multidrug resistance |
| 04/25/2002 | WO2002032864A1 Pharmaceutically active sulfanilide derivatives |
| 04/25/2002 | WO2002032845A2 Method of producing carboxylic acid salts |
| 04/25/2002 | US20020049328 Such as (R)-1-Cyclopropyl-8-difluoromethoxy-7-(1-methyl-2,3-dihydro-1H-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxyl ic acid methanesulfonate; chemical intermediates; bactericides; catalysis |
| 04/25/2002 | US20020049327 Such as 7-(3-chlorophenyl)-9-((4-chlorophenyl)-1H-imidazol-1-ylmethyl)-2,3-dihydro -1H,5H-benzo(ij)quinolizin-5-one; for forming oncogenes for signalling transformation of tumor cells |
| 04/25/2002 | US20020049323 Anxiolytic agents |
| 04/25/2002 | US20020049322 Quinoline and quinazoline compounds useful in therapy |
| 04/25/2002 | US20020049226 Treating obesity, hyperlipidemia, glaucoma, arrhythmia, skin disorders, thyroid disease, hypothyroidism, diabetes mellitus, atherosclerosis, hypertension, coronary heart disease, hypercholesteremia, depression and osteoporosis |
| 04/25/2002 | US20020049194 A benzoazepin or benzodiazepin derivatives, shows excellent anti-vasopressin activity, vasopressin agonistic activity and oxytocin antagonistic activity, and are useful as antagonist |
| 04/25/2002 | US20020049193 Inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity. |
| 04/25/2002 | US20020048687 Efficient light emission and excellent heat resistance |
| 04/25/2002 | CA2423933A1 Pharmaceutically active sulfanilide derivatives |
| 04/24/2002 | EP1198462A1 Process for preparing a 10,11-methanodibenzosuberane derivative |
| 04/24/2002 | EP1198456A2 Potassium channel openers |
| 04/24/2002 | EP1198454A1 Mutilin derivatives and their use as antibacterials |
| 04/24/2002 | EP1198231A1 Bicyclic antagonists selective for the(alpha)v(beta)3 integrin |
| 04/24/2002 | CN1083439C 2-amino-4-bicyclomino-1,3,5-triazines as herbicides and plant growth regulators |
| 04/24/2002 | CN1083432C Process for preparing amine compound and its salt |
| 04/23/2002 | US6376670 Bactericide for grampositive bacteria |
| 04/23/2002 | US6376665 Antiarthritic agents, antiinflammatory agents |
| 04/23/2002 | US6376548 Enhanced propertied pesticides |
| 04/23/2002 | US6376538 Antiinflammatory agents; autoimmune diseases |
| 04/23/2002 | US6376523 Hypotensive agents; antiinflammatory agents; endogenous vasoconstruction peptide |
| 04/23/2002 | US6376514 Piperidine-derived compounds containing a quinolyl group that inhibits p-glycoprotein transport protein activity; for treating cancer and other diseases |
| 04/23/2002 | US6376512 Therapeutic uses of quinoline derivatives |
| 04/23/2002 | US6376511 8-aminoquinolines |
| 04/23/2002 | US6376476 Isoprenoid pathway inhibitors for stimulating bone growth |
| 04/23/2002 | US6376429 Controlling weeds |
| 04/18/2002 | WO2002030931A2 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 04/18/2002 | WO2002030930A2 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 04/18/2002 | WO2002030904A1 Pyridinone derivatives for treatment of atherosclerosis |
| 04/18/2002 | WO2002030903A1 Process for producign optically active ethyl (3r,5s,6e)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxy-6-heptenoate |
| 04/18/2002 | WO2002030881A1 Sulfonylguanidine |
| 04/18/2002 | WO2002000624A3 Methods and compounds for inhibiting mrp1 |
| 04/18/2002 | US20020045777 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes. |